AFP and hepatocellular carcinoma: In a recent article, Hakado et al. propose that the increase of AFP with DCP levels at 24 weeks next to the accomplishment of ribavirin and interferon (IFN) therapy were substantially correlated with the occurrence of HCC irrespective of virological response in Japanese patients with cirrhosis [13,14].